Congress of Clinical Rheumatology West (CCR West), 2024
Filter
Bimekizumab Efficacy Across Subgroups of Patients With Moderate to Severe Plaque Psoriasis: Pooled Analysis From up to 3 Years of Treatment in 5 Phase 3/3b Clinical Trials
Strober Bruce, Krueger G. James, Magnolo Nina, et al.
For US Healthcare Professionals Only